Synaura
Latest round
- Series A
Last raised
- May 2026
Total raised
- $14M
Investors
- 4
About Synaura
, trading as Synaura, is a biotech company that focuses on developing synthetic biology methods. As of 2024, the company has obtained an HMO production license and 2023 Emerging Biotech Enterprises Ranking and People's Craftsmanship and Technology Award certificates. The company's main product is human milk oligosaccharides (HMOs). Breast milk oligosaccharides include neutral fucosylated HMOs, neutral non-fucosylated HMOs, and acidic sialylated HMOs. The company's products are used in infant formula food, adult nutrition products, and milk and dairy products. The company’s revenue is generated by providing human milk oligosaccharides (HMOs).
Who invested in Synaura
4 investors across 2 rounds
See all investors in Synaura
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Synaura
Who invested in Synaura?
Synaura has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Synaura raised?
Synaura has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Synaura last raise money?
Synaura's most recent round on record is a Series A, in May 2026.
What does Synaura do?
, trading as Synaura, is a biotech company that focuses on developing synthetic biology methods.
Where is Synaura headquartered?
Synaura is headquartered in Shanghai, China.
Which VCs invest in companies like Synaura?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Synaura's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Synaura? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.